ACM
DGX icon

Aquatic Capital Management’s Quest Diagnostics DGX Stock Holding History

Aquatic Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,178
Closed -$3.15M – 1473
2025
Q4 		$3.15M Sell
18,178
-24,101
-57% -$4.39M 0.09% 275
2025
Q3 		$8.06M Sell
42,279
-30,050
-42% -$5.33M 0.15% 163
2025
Q2 		$13M Buy
72,329
+63,663
+735% +$11.1M 0.26% 99
2025
Q1 		$1.47M Buy
+8,666
New +$1.42M 0.04% 499
2023
Q4 		– Sell
-9,300
Closed -$1.13M – 1393
2023
Q3 		$1.13M Buy
+9,300
New +$1.24M 0.05% 318

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Aquatic Capital Management's DGX Position: Q1 2026 in Review

Aquatic Capital Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 18,178 shares — an estimated $3.15M sold.

Aquatic Capital Management first reported a position in DGX in Q3 2023 and held it in 5 quarters. The position peaked at $13M in Q2 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Aquatic Capital Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 18,178 Quest Diagnostics shares in Q1 2026, an estimated $3.15M.
  • Aquatic Capital Management first reported a position in Quest Diagnostics in Q3 2023 and held it in 5 quarters.
  • Aquatic Capital Management's Quest Diagnostics position peaked at $13M in Q2 2025.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.